Mary Elizabeth Strek to Cyclic Nucleotide Phosphodiesterases, Type 4
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Cyclic Nucleotide Phosphodiesterases, Type 4.
Connection Strength
0.017
-
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.
Score: 0.017